Compare RPM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPM | MEDP |
|---|---|---|
| Founded | 1947 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paints/Coatings | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 13.0B |
| IPO Year | 1994 | 2016 |
| Metric | RPM | MEDP |
|---|---|---|
| Price | $110.20 | $562.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 12 |
| Target Price | $126.54 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 684.3K | 305.8K |
| Earning Date | 04-08-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | 17.32 | ★ 20.98 |
| EPS | 3.43 | ★ 4.28 |
| Revenue | ★ $5,321,643,000.00 | N/A |
| Revenue This Year | $6.91 | $13.19 |
| Revenue Next Year | $5.15 | $7.75 |
| P/E Ratio | ★ $32.54 | $130.28 |
| Revenue Growth | ★ 7.33 | N/A |
| 52 Week Low | $92.92 | $306.70 |
| 52 Week High | $129.12 | $628.92 |
| Indicator | RPM | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 81.00 |
| Support Level | $104.29 | $551.00 |
| Resistance Level | $113.38 | $622.32 |
| Average True Range (ATR) | 2.52 | 18.76 |
| MACD | 0.07 | 8.14 |
| Stochastic Oscillator | 62.52 | 98.78 |
RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue is from the construction products and North America.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.